Insurance Protects the Investment You Make in Peptides.
Adding peptides to a practice is a real investment. Physicians commit capital to professional-use inventory through Helios Bio Pro, time and tuition to training providers and staff through the Helios Clinical Pro Academy, and resources to the compliance documentation, protocols and patient programs that turn peptides into a recurring service line. That investment is built to pay off over years. A single uninsured claim can undo it in months. Insurance written for peptide risk transfers the financial cost of a claim to an insurer, so what the practice has built stays intact while the claim is defended.
What You Build, and What a Claim Puts at Risk
Every part of a peptide program is capital the practice has committed. Without coverage written for peptide risk, a claim is paid from that same capital.
- Professional-use inventoryProduct sourced through Helios Bio Pro and held for patients
- Provider and staff trainingThe Helios Clinical Pro Academy, protocols and the Clinical Reference
- Compliance build-outConsents, SOPs, documentation workflows and chain of custody
- Practice growthPricing, packaging, enrollment and the recurring patient base behind it
- The practice itselfIts reputation, its revenue and the physician's license behind it
What a Claim Puts at Risk
Without coverage written for peptide risk, the practice funds every dollar of a claim itself:
- Legal fees. $160K–$300K is typical in the first 365 days, before any settlement.
- The settlement or judgment. Paid on top of the cost of defense.
- Indemnification owed. Any obligation the practice accepted in its purchase agreements.
Those costs come out of the same capital the practice invested to build its peptide program. Transferring the risk to an insurer is the surest way to keep that investment protected.
Talk to a WIN Broker →Two Roles, Two Very Different Kinds of Claim
Most peptides aren't FDA approved, and conventional coverage excludes them on both sides: malpractice excludes advisory exposure for non-FDA-approved peptides, and the products liability section of a general liability policy excludes non-FDA-approved peptide products. Protecting a peptide practice takes coverage underwritten specifically for this class of risk.
Professional Liability
A patient alleges injury from negligent care: the wrong recommendation, a missed contraindication, a dosing error. In a conventional practice, malpractice answers this. But because most peptides aren't FDA approved, conventional malpractice policies typically exclude them, leaving peptide advice uninsured unless a policy is written specifically for it.
Products Liability
A patient alleges injury caused by the product itself. In many states, product claims can reach every seller in the distribution chain, sometimes regardless of fault. The question isn't whether you were careful. It's whether the product was defective when it left your hands. The products liability coverage within a conventional general liability policy excludes non-FDA-approved peptide products.
Typical claims exposure in the first 365 days, before any settlement or judgment. A single incident usually produces both a product claim and a professional claim, and the defense costs stack.
Each Party Answers for What It Controls
World Insurance Network describes peptide liability as divided along the supply chain. Responsibility for the product as made flows upstream. Responsibility for what happens after it arrives, and for the recommendation, sits with the practice.
Manufacturer & Distributor
Answer for the product as made: how it was formulated and produced, including contamination or potency variance at the source.
Even so, when a product is blamed, the practice that sold it is commonly named alongside them.
Practice: The Product
Answers for the product once it's in the practice's care: storage, handling, reconstitution, repackaging and providing it to the patient.
Conventional general liability excludes non-FDA-approved peptide products, so this exposure stays uninsured without coverage written specifically for peptides.
Practice: The Recommendation
Answers for the clinical side: the recommendation protocol, contraindication screening, dosing and administration guidance.
Conventional malpractice excludes non-FDA-approved peptides, so this exposure stays uninsured without coverage written specifically for peptides.
In a claim, a practice faces three financial exposures: legal fees, the settlement or judgment, and any indemnification owed under its purchase agreements. Transferring risk to an insurer is the surest way to reduce that financial exposure.
Five Points Where Product Exposure Arises in Practice
Many states shield sellers who simply pass along a sealed product. That protection, and much of the coverage a supplier can extend to you, can narrow once product is stored, reconstituted, repackaged or sent home in the normal course of care. These are the five operational points where that happens, and the Helios control for each.
Four Things Practices Assume, and Shouldn't
Three Claim Scenarios
Adapted from World Insurance Network: two product claims and one professional claim.
Split Vials, Several Infections
A med spa splits multi-dose vials into smaller syringes for take-home use. Several clients develop skin infections. The med spa is named as the seller, and because it altered the product, it can't point upstream.
Product claim. Once the practice repackages the product, responsibility for it shifts to the practice.
A Contaminated Lot
A lot is contaminated at the source. Patients who received it file claims against every party in the chain, including the practice that sold it.
Product claim. Liability may ultimately flow upstream, but the practice is named and must fund its own defense from day one.
A Missed Contraindication
A provider recommends an immune-modulating peptide without reviewing the patient's autoimmune history or medications. The patient is hospitalized.
Professional claim. The question is whether the recommendation met the standard of care.
Eight Questions to Ask a Licensed Insurance Professional
These questions show whether a policy will actually respond to a peptide claim.
- Do I have products liability for what I sell?Conventional general liability excludes non-FDA-approved peptide products, so it has to be coverage written for peptides.
- Are peptides excluded by type or by FDA status?Coverage written specifically for peptides can carry no peptide-type exclusions on either the products or the professional form, regardless of FDA status. Confirm that is true of yours.
- Is the policy claims-made or occurrence?Claims-made coverage depends on continuous renewal and an unchanged retroactive date.
- How are related injuries counted?Whether one bad lot is one claim or many changes how fast limits and deductibles are used.
- Are my limits sized for a peptide claim?With first-year claims exposure of $160K–$300K, per-claim and aggregate limits should fit your patient volume and product mix.
- Does my sourcing keep me eligible?Peptide programs typically require professional-use labeled product from a reputable manufacturer or distributor. Research-use-only or open-market product falls outside eligibility.
- What indemnification have I agreed to?Any indemnity you owe a supplier is a third financial exposure on top of legal fees and settlement. Every purchase agreement should be reviewed by your broker and legal counsel before it is signed.
- Does my broker have access to the markets that write peptide risk?Peptide exposure is placed with specialty carriers. Without access to those markets, a broker can only offer conventional forms that exclude non-FDA-approved peptides.
The Standards Specialty Underwriters Look For
Insurers that write peptide risk typically look for professional-use labeling, physician oversight, documented sourcing, and sound recordkeeping. The Helios model is built around those same operating standards.
Meeting these standards does not guarantee that any insurer will offer coverage. Eligibility, terms and pricing are determined solely by insurers and licensed producers.
Talk to a WIN Broker
Helios does not sell or advise on insurance. For questions about coverage, we refer practices to World Insurance Network, an independent, licensed insurance agency and brokerage serving clients since 2005, with peptide insurance programs for medical practices, clinics and med spas. Any discussion of coverage, eligibility, terms or pricing takes place directly with WIN's licensed brokers.
Practices may use any licensed insurance professional. No Helios purchase is conditioned on buying insurance.
Protect Your Investment: Frequently Asked Questions
Why does a practice that sells peptides have product liability exposure?
In many states, product liability claims can reach every business in the chain of distribution, including the practice or med spa that sold or provided the product to the patient. That exposure exists alongside, and separately from, professional liability for clinical decisions.
Doesn't my malpractice or general liability policy respond to peptide claims?
Usually not. Most peptides aren't FDA approved, and conventional coverage excludes them on both sides: malpractice excludes advisory exposure for non-FDA-approved peptides, and general liability's products coverage excludes non-FDA-approved peptide products. Peptide risk requires coverage underwritten specifically for it, on both the professional and the product side. Only a licensed insurance professional reviewing your actual policy can tell you what it covers.
What can my practice do to reduce product risk?
Put documented procedures around the five operational points where product exposure follows the product: storage, reconstitution, repackaging, labeling and dispensing. Source documented product, keep chain-of-custody records, use consistent consents and patient instructions, and train staff on approved procedures.
Does Helios sell or recommend specific insurance?
No. Helios Consultants and Helios Bio Pro are not licensed insurance producers and do not sell, solicit, negotiate or advise on insurance. We provide general risk education and refer practices to a licensed insurance professional.
Why does sourcing matter for insurability?
Carriers that write peptide risk typically require professional-use labeled product from a reputable manufacturer or distributor, sold through a licensed provider's NPI. Research-use-only and direct-to-consumer product fall outside eligibility. Helios Bio Pro supplies professional-use product only to NPI-verified providers, with Certificates of Analysis by batch.
Review Your Coverage Before You Scale
Put documented controls around the five operational points, and have a licensed insurance professional review your coverage before you grow your peptide program.
This page is general educational information about product and professional liability risk. It is not insurance, legal, or tax advice and is not an offer, solicitation, or recommendation of any insurance product. Helios Consultants, LLC and Helios Bio Pro are not licensed insurance producers and do not sell, solicit, negotiate, or advise on insurance. Insurance products are offered only by licensed producers, including World Insurance Network, Inc., dba WIN Insurance Agency (Nevada Resident Producer Firm License No. 3201506 · NPN 18184569), and only in states where they are licensed. Coverage availability, eligibility, terms, and pricing are determined solely by insurers and licensed producers. Product liability law varies by state; consult your own legal counsel. Scenarios are illustrative. Third-party figures are attributed to their source.